IP Library Granted Patent US 8,048,141
Granted Patent B2
US 8,048,141 · App. 11/006,018 · Granted Nov 1, 2011

Medical device that signals lumen loss

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,141
App. No.
11/006,018
Granted
Nov 1, 2011
Kind
B2
Abstract

Embodiments of the present invention relate to medical devices that provide signals to diagnostic equipment such that functionality of an implantable member can be determined. In particular, various designs and structures are utilized to signal tissue growth on an implantable member such as a stent. The tissue growth can limit flow through the stented lumen. If the growth has a thickness above a certain limit, a signal can be detected by diagnostic equipment such that a proper diagnosis can be made.

Claims (24)

1. A stent, comprising:

a structural element; and

a signaling member coupled to the structural element to signal a level of tissue growth on the structural element, where the signaling member includes a conductive pathway having a switch including a flowable filler material, where the switch closes in response to the level of tissue growth to provide a closed loop electrical pathway on the structural element and the switch includes a cover extending from an outer edge of the conductive pathway to an outer edge of the switch defining an area completely enclosed by the cover where the flowable filler material travels through a portion of the area completely enclosed by the cover to contact the conductive pathway forming the closed loop electrical pathway, where the cover prevents any tissue formation in the area completely enclosed by the cover.

2. The stent of claim 1 , wherein the cover prevents any tissue formation that inhibits travel of the switch.

3. The stent of claim 1 wherein the flowable filler material is conductive and closes the conductive pathway in response to the level of tissue growth on the structural element.

4. The stent of claim 1 wherein the structural element comprises a generally tubular structure.

5. The stent of claim 4 wherein the generally tubular structure includes electrically conductive structural members spaced apart by nonconductive spacers and wherein the signaling member includes a switch that is adapted to electrically couple the electrically conductive structural members in response to the level of tissue growth.

6. The stent of claim 4 , wherein the signaling member comprises a plurality of electrically conductive members extending from an inside surface of the tubular structure.

7. The stent of claim 1 wherein the signaling member includes at least one of platinum, iridium, tantalum, titanium, niobium, hafnium and gold.

8. The stent of claim 1 wherein the signaling member includes a pressure sensitive coating having a piezoelectric material.

9. The stent of claim 1 wherein the signaling member includes an elutable material.

10. The stent of claim 9 wherein the elutable material is a radiopaque coating.

11. The stent of claim 9 wherein the elutable material is a chemical that is detectable in a blood test.

12. The stent of claim 9 wherein the elutable material forms part of the structural element.

13. A stent, comprising:

a generally tubular structure, where the generally tubular structure includes a conductive pathway having a switch including a flowable filler material, where the switch closes in response to a level of tissue growth to provide a closed loop electrical pathway on the generally tubular structure, and a cover extending from an outer edge of the conductive pathway to an outer edge of the switch to define an area completely enclosed by the cover such that the switch travels through a portion of the area completely enclosed by the cover to form the closed loop electrical pathway, where the cover prevents tissue formation in the area completely enclosed by the cover.

14. The stent of claim 13 wherein the generally tubular structure includes electrically conductive structural members spaced apart by nonconductive spacers and wherein the switch is adapted to electrically couple the electrically conductive structural members in response to the level of tissue growth.

15. The stent of claim 13 wherein the generally tubular structure includes at least one of platinum, iridium, tantalum, titanium, niobium, hafnium and gold.

16. The stent of claim 13 , wherein the generally tubular structure includes a plurality of electrically conductive members extending from an inside surface of the tubular structure.

17. The stent of claim 13 wherein the generally tubular structure includes a pressure sensitive coating having a piezoelectric material.

18. The stent of claim 13 wherein the generally tubular structure includes an elutable material.

19. The stent of claim 18 wherein the elutable material is a radiopaque coating.

20. The stent of claim 18 wherein the elutable material is a chemical that is detectable in a blood test.

21. The stent of claim 18 wherein the elutable material forms part of the generally tubular structure.

Assignments (3)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →
MERGER AND CHANGE OF NAME Recorded Dec 16, 2005
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 017362/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2004
From: STINSON, JONATHAN S.
To: SCIMED LIFE SYSTEMS, INC.
Reel/Frame 016078/0857 →